Your browser doesn't support javascript.
loading
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation.
Kim, Ji Hoon; Sohn, Bo Hwa; Lee, Hyun-Sung; Kim, Sang-Bae; Yoo, Jeong Eun; Park, Yun-Yong; Jeong, Woojin; Lee, Sung Sook; Park, Eun Sung; Kaseb, Ahmed; Kim, Baek Hui; Kim, Wan Bae; Yeon, Jong Eun; Byun, Kwan Soo; Chu, In-Sun; Kim, Sung Soo; Wang, Xin Wei; Thorgeirsson, Snorri S; Luk, John M; Kang, Koo Jeong; Heo, Jeonghoon; Park, Young Nyun; Lee, Ju-Seog.
Afiliación
  • Kim JH; Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Kleberg Center for Molecular Markers, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Sohn BH; Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Kleberg Center for Molecular Markers, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Lee HS; Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Kleberg Center for Molecular Markers, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Kim SB; Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Kleberg Center for Molecular Markers, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Yoo JE; Department of Pathology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
  • Park YY; ASAN Institute for Life Sciences, Asan Medical Center, Department of Medicine, University of Ulsan College of Medicine, Seoul, Korea.
  • Jeong W; Department of Life Sciences, Division of Life and Pharmaceutical Sciences, Center for Cell Signaling and Drug Discovery Research, Ewha Womans University, Seoul, Korea.
  • Lee SS; Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
  • Park ES; Institute for Medical Convergence, Yonsei University College of Medicine, Seoul, Korea.
  • Kaseb A; Department of GI Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Kim BH; Department of Pathology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Kim WB; Department of Surgery, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Yeon JE; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Byun KS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Chu IS; Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.
  • Kim SS; Department of Biochemistry and Molecular Biology, Medical Research Center and Biomedical Science Institute, School of Medicine, Kyung Hee University, Seoul, Korea.
  • Wang XW; Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Thorgeirsson SS; Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Luk JM; Department of Pharmacology, National University of Singapore, Singapore.
  • Kang KJ; Department of Surgery, Keimyung University School of Medicine, Daegu, Korea.
  • Heo J; Departments of Molecular Biology and Immunology, Kosin University College of Medicine, Busan, Korea.
  • Park YN; Department of Pathology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
  • Lee JS; Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Kleberg Center for Molecular Markers, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
PLoS Med ; 11(12): e1001770, 2014 Dec.
Article en En | MEDLINE | ID: mdl-25536056
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos